Liberty Biopharma (CVE:LTY) Stock Passes Below 200-Day Moving Average of $2.00

Shares of Liberty Biopharma Inc (CVE:LTY – Get Rating) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares changing hands.

Liberty Biopharma Stock Up ∞

The business’s 50-day moving average is C$2.00 and its two-hundred day moving average is C$2.00. The stock has a market capitalization of C$21.54 million and a price-to-earnings ratio of -12.66. The company has a quick ratio of 0.12, a current ratio of 0.12 and a debt-to-equity ratio of 8.19.

About Liberty Biopharma

(Get Rating)

Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.